Top Markets
Coin of the day
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc.

RGRX
株式のランク #42502
RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the... RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the advancement of therapeutic peptides, with a primary emphasis on thymosin beta 4, engineered for the protection, repair, and regeneration of tissues and organs. The company's development pipeline includes RGN-259, a preservative-free ophthalmic solution designed to restore corneal tissues following injury, disease, or other pathologies; RGN-352, an injectable formulation under investigation for its potential in treating cardiovascular ailments, central and peripheral nervous system disorders, and various other medical conditions; and RGN-137, a topical gel aimed at accelerating the healing of skin wounds and minimizing scar tissue. Strategic alliances have been forged with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. Incorporated in 1982, the company initially operated as Alpha 1 Biomedicals, Inc., adopting the name RegeneRx Biopharmaceuticals, Inc. in 2000. Its operations are headquartered in Rockville, Maryland.
株価
$0.0007
最終同期: 2026-08-11
時価総額
$1.05K
変化(1日)
0.00%
変化(1年)
250.00%
US
取引 RegeneRx Biopharmaceuticals, Inc. (RGRX)

カテゴリー

RegeneRx Biopharmaceuticals, Inc.(RGRX)の株価履歴
終値の最高値: $0.00 (2026-08-01)

終値の最安値: $110.06 (2003-10-01)
RegeneRx Biopharmaceuticals, Inc. の株価履歴(2003 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 0.00%
2025 -97.59%
2024 1,141.64%
2023 -99.99%
2022 -11.40%
2021 -67.94%
2020 258.85%
2019 26.29%
2018 -40.52%
2017 -42.65%
2016 -16.88%
2015 184.48%
2014 141.27%
2013 -42.28%
2012 -20.49%
2011 -48.51%
2010 -59.48%
2009 -54.58%
2008 16.64%
2007 -51.00%
2006 -27.91%
2005 -24.03%
2004 365.32%
2003 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR